Description: Abstracts of recent articles of interest to health actuaries

Description: Interview with John Houston, Advanced Analytics and Predictive Modeling practice leader at Deloitte.

Description: A discussion on how the look of charts and graphs can affect comprehension of data.

Description: Even the best algorithms are only effective if they are trained on appropriate data. This article discusses common pitfalls in creating a training data set.

Description: Further explore the pipeline of large claims approaching in the future in this webcast. Some of these upcoming claims include Cell and Gene Therapies, as well as high medical costs. In order to prepare for the multitude of claims, this session provides the insurance industry with an overview of what these large claims consist of. You can also expect important recommendations on how to properly prepare for them to succeed in this market.

Description: This article discusses the use of parametric distributions to model health care cost.

Description: Feature article discussing futurism and a study that contains in-depth descriptions of the Delphi and TIA methods; listings of the rationales and thought processes, the plausible future developments that could influence the values of these four economic variables and the resulting “fan of possibilities” for the values of these variables

Description: Results of a survey of healthcare organizations regarding use and plans for Predictive Analytics

Description: Explore insights to non-traditional actuarial roles from a panelist with experiences in data science, finance and entertainment. The panelist will be sharing their perspectives on their non-traditional actuarial role in relation to the actuarial profession.

Description: Renal disease is a very heterogenous medical condition whose end state is dialysis, a recurring cost intensive medical condition. Dialysis cost is one of the major medical cost drivers in USA. Insufficient and improper care management in the early stages of CKD (chronic kidney disease) leads to early incidence of end stage renal disease (ESRD) among CKD patients which not only leads to high medical costs, but also reflects poor health quality.